NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
20 hedge funds and large institutions have $35.8M invested in Nexvet Biopharma plc Ordinary Shares in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$803K | |
| 2 | +$702K | |
| 3 | +$588K | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$569K |
| 5 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$476K |
Top Sellers
| 1 | -$3.41M | |
| 2 | -$602K | |
| 3 | -$408K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$173K |
| 5 |
Citigroup
New York
|
-$21K |
